Search For Lab Tests Here

The Epstein-Barr Virus Antibody (EBV) Panel detects antibodies to EBV, including VCA IgM, VCA IgG, and EBNA IgG, to determine current, recent, or past infection. EBV causes infectious mononucleosis and has links to chronic fatigue and certain cancers. Doctors order this test for patients with fever, sore throat, swollen lymph nodes, or fatigue. Results help identify stage of infection, confirm diagnosis, and guide clinical management of EBV-related illness.

The Coxsackie B Virus Antibodies test is a diagnostic blood test used to detect antibodies produced by the immune system in response to a Coxsackie B virus infection. Coxsackie B viruses belong to the enterovirus family and are associated with a range of illnesses, from mild flu-like symptoms to more severe conditions such as viral myocarditis and meningitis. This test measures the presence of specific antibodies against Coxsackie B viruses, helping to confirm recent or past infections and assess the immune response to the virus. The test is particularly useful in identifying cases where Coxsackie B virus may be the underlying cause of unexplained cardiac, neurological, or systemic symptoms.

The Varicella Zoster Virus IgG IgM Antibodies Panel is used to assess exposure to the varicella-zoster virus, which causes both chickenpox and shingles. By evaluating the presence and levels of specific antibodies, this panel aids in diagnosing current infections, determining immunity, and guiding vaccination decisions.

The Varicella IgM Antibody Test measures IgM antibodies produced in response to varicella-zoster virus, helping identify current or recent chickenpox infection. It aids in differentiating acute illness from prior exposure or immunity. This test supports evaluation of symptoms such as rash, fever, or fatigue, and provides valuable information about immune activity and viral health risks.

The Mumps Virus Titer Test measures IgG antibodies to determine immunity from prior infection or vaccination. A positive result indicates protective immunity, while a negative result suggests susceptibility to mumps. Doctors use this blood test to confirm immune status, check vaccine response, or meet school, travel, or employment requirements. It provides valuable information for individual protection and public health safety.

The Varicella Titer Test is a blood test that measures antibodies to the varicella-zoster virus (VZV), which causes chickenpox and shingles. A positive result indicates past infection, while a negative suggests no exposure. This test is not considered reliable for confirming immunity from vaccination. Doctors use it to evaluate history of natural infection, meet school or work requirements, and provide documentation of varicella exposure status.

 The Immunity Panel is a set of laboratory tests designed to assess an individual's immunity status against specific infectious diseases. By measuring the presence and levels of specific antibodies in the blood, the panel provides valuable insights into whether an individual has been previously exposed to these pathogens or has been vaccinated against them, thus offering protection.

The Immunity Panel Plus is a comprehensive set of tests designed to evaluate an individual's immunity to certain infectious diseases. This panel includes tests for Hepatitis A Antibody Total, Hepatitis B Surface Antibody, Quantitative, Measles IgG Antibody, Mumps IgG Antibody, Rubella IgG Antibody, and Varicella-Zoster Virus IgG Antibody. It is often used to determine if an individual has immunity, either from previous infections or vaccinations, against these specific diseases.

The Student Titers Panel evaluates immunity to key infections often required for school or healthcare enrollment. It includes Hepatitis B Surface Antibody, Measles IgG, Mumps IgG, Rubella IgG, Varicella-Zoster Virus IgG, and QuantiFERON-TB Gold Plus for tuberculosis. Results confirm vaccination response or past exposure, helping students meet program requirements and ensure protection against preventable diseases.

The Epstein-Barr Virus (EBV) Viral Capsid Antigen (VCA) IgG Antibody Test detects IgG antibodies that appear after EBV infection and usually persist for life. Positive results indicate past exposure or infection with EBV, the virus that causes mononucleosis. Doctors order this test with VCA IgM and EBNA IgG to determine infection stage. Results help confirm prior EBV exposure, support diagnosis, and guide evaluation of EBV-related conditions.

The Epstein-Barr Virus (EBV) Nuclear Antigen (EBNA) IgG Antibody Test detects IgG antibodies that usually appear after acute infection, confirming past exposure or infection recovery. Doctors order this test alongside VCA and EA antibodies to determine the stage of EBV infection. Results help distinguish recent versus past EBV, guide diagnosis of mononucleosis, and support evaluation of chronic fatigue or EBV-related health conditions.

The Herpes Simplex Virus 1 IgG Type-Specific Antibody HerpeSelect® Test detects IgG antibodies to HSV-1, the virus commonly associated with oral herpes. A positive result indicates past exposure, as IgG develops weeks after infection and remains for life. Doctors use this test to confirm HSV-1 infection, evaluate unexplained sores, or guide sexual health management. Results provide essential insight into infection history, immune response, and long-term HSV-1 status.

The Epstein-Barr Virus (EBV) Early Antigen D IgG Antibody Test detects IgG antibodies to EBV’s early antigen, helping identify recent or reactivated infection. Elevated levels may indicate acute mononucleosis, viral reactivation, or chronic EBV. Doctors order this test when patients present with fatigue, fever, sore throat, or swollen lymph nodes. Results provide key insight into EBV activity, supporting diagnosis, monitoring, and treatment decisions.

The Epstein-Barr Virus (EBV) Viral Capsid Antigen (VCA) IgM Antibody Test detects IgM antibodies, which appear early during EBV infection. A positive result usually indicates recent or acute infection, including mononucleosis. Doctors order this test for patients with fever, sore throat, fatigue, or swollen lymph nodes. Results help confirm acute EBV infection, distinguish it from past exposure, and support accurate diagnosis and treatment decisions.

The Herpes Simplex Virus 1 and 2 IgG Type-Specific Antibody HerpeSelect® Test detects IgG antibodies to HSV-1 and HSV-2, distinguishing between the two types. A positive result indicates past exposure, as IgG develops weeks after infection and remains long-term. Doctors use this test to confirm herpes diagnosis, guide treatment, or support sexual health decisions. Results provide vital insight into HSV status, infection history, and long-term immune response.

The Epstein-Barr Virus (EBV) Viral Capsid Antigen (VCA) IgA Antibody Test detects IgA antibodies that may indicate recent or reactivated EBV infection. Elevated IgA levels are often associated with nasopharyngeal carcinoma and other EBV-related conditions. Doctors order this test for patients with persistent sore throat, swollen lymph nodes, or suspected EBV reactivation. Results provide valuable insight for diagnosis, cancer risk assessment, and ongoing monitoring.